$17.43
0.000.00%
Pre-Market: 4:24 PM EDT
Comments
Loading...
IDEAYA Biosciences Insider Trading Activity | NASDAQ:IDYA | Benzinga
Track the latest IDEAYA Biosciences insider trading activity. Stay informed on recent buys, sells, and market impact for IDEAYA Biosciences stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are IDEAYA Biosciences Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
There has been no Insider buying or selling in the last 90 days.
Ownership Statistics for IDEAYA Biosciences Inc
Shares Outstanding
87.537M
Insider Shares Owned
1.015M
Insider Percentage Owned
1.16%
Institutional Shares Held
66.370M
Institutional Percentage Held
75.8%
| May 31, 2024 | Michael Anthony White | CHIEF SCIENTIFIC OFFICER | 0.00 | $24.55 | -$666.37K | SELL-OPTIONS | 0.00% | 0.00 | May 29 | View |
| May 16, 2024 | Yujiro Hata | PRESIDENT AND CEO | 0.00 | $23.29 | -$6.64M | SELL-OPTIONS | 0.00% | 677.89K | May 14 - May 16 | View |
| Feb 13, 2024 | Andres Ruiz Briseno | SEE REMARKS | -2.00K | $46.02 | -$92.04K | SELL | -7.54% | 24.53K | Feb 09 | View |
| Feb 12, 2024 | Yujiro Hata | PRESIDENT AND CEO | 0.00 | $24.77 | -$4.07M | SELL-OPTIONS | 0.00% | 677.89K | Feb 08 - Feb 09 | View |
| Feb 05, 2024 | Yujiro Hata | PRESIDENT AND CEO | 0.00 | $24.66 | -$25.55K | SELL-OPTIONS | 0.00% | 677.89K | Feb 01 | View |
| Jan 24, 2024 | Andres Ruiz Briseno | SEE REMARKS | -2.00K | $42.03 | -$84.05K | SELL | -7.01% | 26.53K | Jan 22 | View |
| Jan 17, 2024 | Andres Ruiz Briseno | SEE REMARKS | -2.00K | $38.01 | -$76.03K | SELL | -6.55% | 28.53K | Jan 12 | View |
| Jan 17, 2024 | Yujiro Hata | PRESIDENT AND CEO | 0.00 | $22.23 | -$2.69M | SELL-OPTIONS | 0.00% | 677.89K | Jan 12 - Jan 16 | View |
| Dec 19, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 10.00K | $22.61 | -$146.87K | SELL-OPTIONS | ∞ | 10.00K | Dec 15 - Dec 18 | View |
| Dec 19, 2023 | Yujiro Hata | PRESIDENT AND CEO | 0.00 | $19.67 | -$2.30M | SELL-OPTIONS | 0.00% | 677.89K | Dec 15 | View |
| Dec 18, 2023 | Andres Ruiz Briseno | SEE REMARKS | -2.00K | $34.00 | -$68.00K | SELL | -6.15% | 30.53K | Dec 14 | View |
| Nov 07, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 0.00 | $21.48 | -$88.96K | SELL-OPTIONS | 0.00% | 0.00 | Nov 03 | View |
| Sep 14, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 0.00 | $21.43 | -$17.14K | SELL-OPTIONS | 0.00% | 0.00 | Sep 12 | View |
| Sep 06, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 0.00 | $21.44 | -$65.88K | SELL-OPTIONS | 0.00% | 0.00 | Sep 01 - Sep 05 | View |
| Sep 06, 2023 | Andres Ruiz Briseno | SEE REMARKS | -2.00K | $30.01 | -$60.02K | SELL | -5.79% | 32.53K | Sep 01 | View |
| Aug 31, 2023 | Paul A Stone | CHIEF FINANCIAL OFFICER | -5.00K | $28.87 | -$144.35K | SELL | -34.96% | 9.30K | Aug 29 | View |
| Aug 23, 2023 | Paul A Stone | CHIEF FINANCIAL OFFICER | -978.00 | $26.40 | -$25.82K | SELL | -6.40% | 14.30K | Aug 21 | View |
| Aug 18, 2023 | Paul A Stone | CHIEF FINANCIAL OFFICER | -4.02K | $26.38 | -$106.11K | SELL | -20.84% | 15.28K | Aug 16 - Aug 18 | View |
| Aug 11, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 0.00 | $19.21 | -$58.73K | SELL-OPTIONS | 0.00% | 0.00 | Aug 09 | View |
| Aug 11, 2023 | Paul A Stone | CHIEF FINANCIAL OFFICER | -2.50K | $25.05 | -$62.61K | SELL | -11.47% | 19.30K | Aug 09 | View |
| Jul 12, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 0.00 | $16.55 | -$122.44K | SELL-OPTIONS | 0.00% | 0.00 | Jul 10 | View |
| Jun 02, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 0.00 | $15.01 | -$63.79K | SELL-OPTIONS | 0.00% | 0.00 | May 31 - Jun 01 | View |
| May 24, 2023 | Jason Throne | CHIEF LEGAL OFFICER | 0.00 | $15.00 | -$8.00K | SELL-OPTIONS | 0.00% | 0.00 | May 22 | View |
| Oct 07, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $18.72 | -$22.93K | SELL-OPTIONS | 0.00% | 78.79K | Oct 04 | View |
| Sep 09, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $17.13 | -$236.51K | SELL-OPTIONS | 0.00% | 78.79K | Sep 07 - Sep 08 | View |
| Sep 09, 2021 | Paul A Stone | SVP, CHIEF FINANCIAL OFFICER | -2.50K | $27.42 | -$68.54K | SELL | -16.19% | 12.94K | Sep 07 | View |
| Sep 07, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | -10.00K | $25.09 | -$250.94K | SELL | -11.26% | 78.79K | Sep 02 | View |
| Aug 11, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | -10.00K | $13.64 | -$257.80K | SELL | -10.12% | 88.79K | Aug 09 | View |
| Jul 29, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $15.38 | -$195.31K | SELL-OPTIONS | 0.00% | 98.79K | Jul 27 | View |
| Jul 29, 2021 | Jason Throne | SVP, GENERAL COUNSEL | 0.00 | $19.25 | -$118.28K | SELL-OPTIONS | 0.00% | 0.00 | Jul 27 | View |
| Jul 08, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $14.58 | -$22.98K | SELL-OPTIONS | 0.00% | 98.79K | Jul 06 | View |
| Jul 08, 2021 | Jason Throne | SVP, GENERAL COUNSEL | 0.00 | $15.38 | -$137.18K | SELL-OPTIONS | 0.00% | 0.00 | Jul 06 | View |
| Jun 17, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $14.70 | -$77.81K | SELL-OPTIONS | 0.00% | 98.79K | Jun 16 - Jun 17 | View |
| Jun 09, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $13.57 | -$19.95K | SELL-OPTIONS | 0.00% | 98.79K | Jun 07 | View |
| May 13, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $13.57 | -$66.49K | SELL-OPTIONS | 0.00% | 98.79K | May 11 | View |
| Feb 10, 2021 | Michael P Dillon | SVP, CHIEF SCIENTIFIC OFFICER | 0.00 | $13.83 | -$69.10K | SELL-OPTIONS | 0.00% | 98.79K | Feb 09 | View |
| Feb 10, 2021 | Mark Lackner | SVP, HEAD BIOLOGY | 0.00 | $14.00 | -$28.09K | SELL-OPTIONS | 0.00% | 0.00 | Feb 08 - Feb 10 | View |
| Feb 04, 2021 | PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | — | -46.41K | $18.00 | -$835.36K | SELL | -16.60% | 233.15K | Feb 02 | View |
| Jan 28, 2021 | Mark Lackner | SVP, HEAD BIOLOGY | -1.00K | $12.42 | -$36.58K | SELL | -100.00% | 0.00 | Jan 26 | View |
| Dec 08, 2020 | Jason Throne | — | -1.98K | $15.37 | -$30.41K | SELL | -100.00% | 0.00 | Dec 04 | View |
| Nov 13, 2020 | AM Ventures IV LPAM CoInvestors IV LPAM Partners IV LLCAM Opportunities I LPAM Opportunities I GP LLCJOHN DIEKMANAndrew SchwabSCOTT ROCKLAGE | — | -800.00K | $13.66 | -$10.93M | SELL | -67.54% | 384.50K | Nov 11 | View |
| Jul 02, 2020 | PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | — | 2.53K | $13.32 | $33.70K | PURCHASE | 1.08% | 237.47K | Jun 30 | View |
| Jun 22, 2020 | PIL PARTNERS BVFFUND VALUE BIOTECHNOLOGYBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | — | 118.00K | $14.31 | $1.69M | PURCHASE | 98.83% | 237.39K | Jun 19 - Jun 22 | View |
| Jun 19, 2020 | Paul A Stone | — | 0.00 | $11.30 | -$41.39K | OPTION EXERCISE | 0.00% | 15.00K | Jun 17 | View |
| Jun 18, 2020 | Mark Lackner | — | 0.00 | $10.38 | -$68.52K | OPTION EXERCISE | 0.00% | 0.00 | Jun 16 - Jun 17 | View |
| Jun 08, 2020 | Jason Throne | — | -2.21K | $8.66 | -$19.09K | SELL | -100.00% | 0.00 | Jun 04 | View |
| Jun 04, 2020 | Mark Lackner | — | -845.00 | $9.21 | -$7.78K | SELL | -100.00% | 0.00 | Jun 02 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.